Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency

OBJECTIVE: On the basis of our previous work with triheptanoin, which provides key substrates to the Krebs cycle in the brain, we wished to assess its therapeutic effect in patients with glucose transporter type 1 deficiency syndrome (GLUT1-DS) who objected to or did not tolerate ketogenic diets. ME...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurol Neurosurg Psychiatry
Main Authors: Mochel, Fanny, Hainque, Elodie, Gras, Domitille, Adanyeguh, Isaac M, Caillet, Samantha, Héron, Bénédicte, Roubertie, Agathe, Kaphan, Elsa, Valabregue, Romain, Rinaldi, Daisy, Vuillaumier, Sandrine, Schiffmann, Raphael, Ottolenghi, Chris, Hogrel, Jean-Yves, Servais, Laurent, Roze, Emmanuel
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Movement Disorders
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4853553/
https://ncbi.nlm.nih.gov/pubmed/26536893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2015-311475
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados